Point Nemo Capital
TAK icon

Point Nemo Capital’s Takeda Pharmaceutical TAK Stock Holding History

Point Nemo Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.45M Buy
+79,902
New +$1.41M 0.68% 44

Other funds holding TAK

Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Clean Yield Group
Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return
Catalyst Capital Advisors
Catalyst Capital Advisors Huntington, New York $6.21B AUM 15.35% 1-Year Est. Return
Carrera Capital Advisors
Carrera Capital Advisors Troy, Michigan $705M AUM 12.86% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return

Point Nemo Capital's TAK Position: Q3 2026 in Review

Point Nemo Capital opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 79,902 shares worth $1.45M. The stake represents 0.68% of the portfolio and ranks #44 among its holdings.

155 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Point Nemo Capital held 79,902 shares of Takeda Pharmaceutical worth $1.45M as of Q3 2026.
  • Takeda Pharmaceutical was a new Point Nemo Capital position in Q3 2026.
  • Takeda Pharmaceutical made up 0.68% of Point Nemo Capital's portfolio in Q3 2026, its #44 holding.
  • 155 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Point Nemo Capital's 13F filing for Q3 2026, filed 3 Nov 2026.